These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18606700)

  • 1. Systemic release of high mobility group box 1 protein during severe murine influenza.
    Alleva LM; Budd AC; Clark IA
    J Immunol; 2008 Jul; 181(2):1454-9. PubMed ID: 18606700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections.
    Patel MC; Shirey KA; Boukhvalova MS; Vogel SN; Blanco JCG
    mBio; 2018 Mar; 9(2):. PubMed ID: 29535197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethyl pyruvate attenuates murine allergic rhinitis partly by decreasing high mobility group box 1 release.
    Chen S; Wang Y; Gong G; Chen J; Niu Y; Kong W
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1490-9. PubMed ID: 25681468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-high mobility group box-1 monoclonal antibody treatment of brain edema induced by influenza infection and lipopolysaccharide.
    Nosaka N; Hatayama K; Yamada M; Fujii Y; Yashiro M; Wake H; Tsukahara H; Nishibori M; Morishima T
    J Med Virol; 2018 Jul; 90(7):1192-1198. PubMed ID: 29573352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of high-mobility group box 1 protein in the pathogenesis of influenza H5N1 virus infection.
    Hou XQ; Qin JL; Zheng XX; Wang L; Yang ST; Gao YW; Xia XZ
    Acta Virol; 2014; 58(1):69-75. PubMed ID: 24717031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice.
    Nosaka N; Yashiro M; Yamada M; Fujii Y; Tsukahara H; Liu K; Nishibori M; Matsukawa A; Morishima T
    Crit Care; 2015 Jun; 19(1):249. PubMed ID: 26067826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethyl pyruvate inhibits the acetylation and release of HMGB1 via effects on SIRT1/STAT signaling in LPS-activated RAW264.7 cells and peritoneal macrophages.
    Kim YM; Park EJ; Kim JH; Park SW; Kim HJ; Chang KC
    Int Immunopharmacol; 2016 Dec; 41():98-105. PubMed ID: 27865166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid and HMGB1 are involved in the induction of autoantibodies elicited in mice infected with mouse hepatitis virus A59.
    Duhalde-Vega M; Retegui LA
    Autoimmunity; 2011 Dec; 44(8):631-40. PubMed ID: 21604970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective study.
    Gaïni S; Pedersen SS; Koldkjaer OG; Pedersen C; Møller HJ
    Crit Care; 2007; 11(2):R32. PubMed ID: 17346334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-high mobility group box 1 monoclonal antibody suppressed hyper-permeability and cytokine production in human pulmonary endothelial cells infected with influenza A virus.
    Namba T; Tsuge M; Yashiro M; Saito Y; Liu K; Nishibori M; Morishima T; Tsukahara H
    Inflamm Res; 2021 Dec; 70(10-12):1101-1111. PubMed ID: 34455489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic and local high mobility group box 1 concentrations during severe infection.
    van Zoelen MA; Laterre PF; van Veen SQ; van Till JW; Wittebole X; Bresser P; Tanck MW; Dugernier T; Ishizaka A; Boermeester MA; van der Poll T
    Crit Care Med; 2007 Dec; 35(12):2799-804. PubMed ID: 17901841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic release of high mobility group box 1 (HMGB1) protein is associated with severe and fatal Plasmodium falciparum malaria.
    Higgins SJ; Xing K; Kim H; Kain DC; Wang F; Dhabangi A; Musoke C; Cserti-Gazdewich CM; Tracey KJ; Kain KC; Liles WC
    Malar J; 2013 Mar; 12():105. PubMed ID: 23506269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penehyclidine hydrochloride inhibits the release of high-mobility group box 1 in lipopolysaccharide-activated RAW264.7 cells and cecal ligation and puncture-induced septic mice.
    Yang Q; Liu X; Yao Z; Mao S; Wei Q; Chang Y
    J Surg Res; 2014 Jan; 186(1):310-7. PubMed ID: 24124976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
    Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
    Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation.
    Ulloa L; Ochani M; Yang H; Tanovic M; Halperin D; Yang R; Czura CJ; Fink MP; Tracey KJ
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12351-6. PubMed ID: 12209006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis.
    McClellan S; Jiang X; Barrett R; Hazlett LD
    J Immunol; 2015 Feb; 194(4):1776-87. PubMed ID: 25589066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirt1 S-nitrosylation induces acetylation of HMGB1 in LPS-activated RAW264.7 cells and endotoxemic mice.
    Kim YM; Park EJ; Kim HJ; Chang KC
    Biochem Biophys Res Commun; 2018 Jun; 501(1):73-79. PubMed ID: 29680657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine inhibits LPS-induced HGMB1 release in vitro and in vivo.
    Zhang Z; Zhang L; Zhou C; Wu H
    Int Immunopharmacol; 2014 Nov; 23(1):14-26. PubMed ID: 25133650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethyl pyruvate inhibits HMGB1 phosphorylation and secretion in activated microglia and in the postischemic brain.
    Shin JH; Lee HK; Lee HB; Jin Y; Lee JK
    Neurosci Lett; 2014 Jan; 558():159-63. PubMed ID: 24246904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethyl pyruvate ameliorates experimental colitis in mice by inhibiting the HMGB1-Th17 and Th1/Tc1 responses.
    Guo X; Guo R; Luo X; Zhou L
    Int Immunopharmacol; 2015 Dec; 29(2):454-461. PubMed ID: 26541861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.